CION Ameerpet
A borderline ovarian tumour is not invasive cancer, and it is most often found in women who have not finished having their family. Keeping your uterus and your unaffected ovary is an accepted, guideline-backed option here — not a favour someone is doing you, and not a gamble you are being allowed to take. What follows is what that choice involves, and what it genuinely trades.
For most women, yes — and that is not a kindness offered to soften the diagnosis. It follows from what a borderline tumour is. The cells pile up in layers and look atypical, but they do not invade and destroy the ovarian tissue around them. Because there is no invasion, the operation does not have to be radical to be adequate, and removing both ovaries and the uterus is not the default the way it often is in invasive ovarian cancer.
If you have been searching borderline ovarian tumour fertility since the phone call, hold on to this: keeping your uterus and your unaffected ovary is an accepted option in this disease, written into international guidance, and not something you have to argue a surgeon into. Most borderline tumours are confined to one ovary when they are found, and pregnancy after fertility-sparing surgery is common rather than remarkable.
What changes the plan is detail, not fear. Which subtype the pathologist reported. Whether one ovary is involved or both. Whether deposits were found outside the ovary, and of which type. Whether the abdomen was properly looked at during the first operation. Those four lines decide far more than your age does. Start with what a borderline ovarian tumour actually is, then come back to the fertility question with the report in your hand.
Because borderline cells do not invade, chemotherapy has no established role. Your fertility is not competing with a course of treatment that damages the ovaries.
Most borderline tumours are confined to one ovary at diagnosis. That is precisely the situation in which sparing the other ovary and the uterus is reasonable.
Borderline tumours are diagnosed at a markedly younger average age than invasive ovarian cancer, which is why fertility is a routine part of the conversation, not an afterthought.
Fertility-sparing surgery in borderline ovarian tumours is not an exception granted to young women — it is written into guideline care. NCCN recognises fertility-sparing surgery, preserving the uterus and at least part of one ovary, as an option for women with borderline (low malignant potential) tumours who wish to keep the possibility of pregnancy. The published trade-off is specific and worth knowing: removing only the cyst leaves more ovarian tissue but recurs more often than removing the affected ovary and tube, and those recurrences are usually borderline again and treatable with further surgery, without a demonstrated cost in survival. The 5th edition of the WHO classification also changed the language: deposits outside the ovary once called “invasive implants” are now classified and managed as low-grade serous carcinoma, which is a different disease with a different fertility conversation. Source: NCCN Ovarian Cancer guidelines; WHO Classification of Tumours — Female Genital Tumours, 5th edition (2020).
This is the decision that actually shapes your fertility, and it is a genuine trade rather than a right and a wrong answer. The honest version of each option is below.
| The operation | When it is considered | The trade-off |
|---|---|---|
| Cystectomy — the cyst alone | Both ovaries involved, only one ovary remaining, or a young woman with limited ovarian reserve who wants to keep every follicle she has. | Keeps the most ovarian tissue, and recurs more often than removing the ovary. Recurrence is usually borderline again and removable, but it means further surgery — and each operation on the same ovary costs reserve. |
| Salpingo-oophorectomy — the affected ovary and tube | One ovary involved, the other looking normal, and reasonable reserve on the remaining side. | The lower recurrence rate of the fertility-sparing options, at the cost of half your ovarian tissue. The uterus and the other ovary stay, so both natural conception and treatment cycles remain possible. |
| Surgical staging alongside either | Almost always advised, and frequently missed at a first operation done for what everyone assumed was an ordinary cyst. | Adds washings and omental and peritoneal sampling, which is what finds deposits outside the ovary. Skipping it does not make the disease smaller — it makes the follow-up blinder. |
| Removing both ovaries and the uterus | Invasive implants (now classified as low-grade serous carcinoma), extensive bilateral disease, or a woman who has completed her family. | Definitive, and the end of fertility. It should be a decision taken with the full report in front of you, not a precaution taken because nobody asked whether you wanted children. |
*Any of these operations — cystectomy, ovary-sparing surgery, staging or a later completion operation — is coordinated with specialist gynaecologic-oncology partner centres and may be billed there. CION plans it with you and manages everything around it; we do not perform the surgery ourselves, and we would rather say that now.
None of these closes the door by itself. Each one is a reason to have the plan reviewed by people who see borderline tumours regularly, before a second operation is booked.
Under the current WHO classification these are low-grade serous carcinoma, not borderline disease. That is a different diagnosis and a different fertility conversation.
Serous borderline tumours are bilateral more often than mucinous ones. Cyst-only surgery on both sides can preserve fertility, at a higher chance of coming back.
Both are recognised markers of a higher recurrence risk. They usually change the intensity of follow-up rather than ruling fertility-sparing surgery out.
If the first operation was done for a presumed simple cyst, washings and omental sampling were probably skipped. That gap needs a decision, not an assumption.
Repeat cystectomy on the same ovary removes normal tissue each time. Measure reserve before agreeing to it, not afterwards.
New pain, a new cyst on a follow-up scan, or a mass found while trying to conceive should be assessed promptly rather than watched for months.
If any of these apply, ask for the case to be reviewed before the next operation is scheduled. In borderline disease the sequence of decisions matters as much as the decisions themselves — a staging operation planned properly costs you less ovarian tissue than two operations planned separately.
A 45-minute consultation, your pathology report read line by line, and a plan that puts ovarian reserve and staging in the same conversation instead of in two separate ones. The first consultation is free.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. Bring the pathology report and the operation notes — between them they answer most of what you came to ask.
Most of the fertility that gets lost in borderline disease is lost to sequence, not to the tumour: a second operation booked before anyone measured ovarian reserve, or a decision about the uterus taken before the pathology was re-read.
Subtype, growth pattern, microinvasion, and whether any deposits outside the ovary were invasive or non-invasive. Reports written before the 5th edition of the WHO classification may use wording your current team no longer uses. Nothing about your fertility should be decided until those lines are settled.
Anti-Mullerian hormone and an antral follicle count take one visit. They convert “you are young, you will be fine” into a number, and they occasionally change the choice between removing another cyst and removing the ovary.
If reserve is already low or both ovaries are involved, oocyte or embryo freezing is worth discussing before surgery rather than once tissue is gone. This is done at a reproductive medicine unit — CION coordinates the referral and the timing around your surgery; the cycle itself is not performed here.
Washings, omental and peritoneal sampling, and appendix assessment for mucinous tumours can all be done while preserving the uterus and the unaffected ovary. Surgery is coordinated with specialist gynaecologic-oncology partner centres, so the plan is agreed with the operating team before you are booked, not discovered in the discharge summary.
Guidelines do not impose a fixed waiting period after fertility-sparing surgery for a borderline tumour, and many women conceive naturally. Where conception does not happen, treatment cycles are usually possible — a decision taken jointly by your gynaecologic oncologist and the fertility unit, with your subtype and staging on the table. See fertility and ovarian cancer treatment for the wider picture.
Follow-up scans of the preserved ovary run for years, because borderline tumours can return late. Removing the remaining ovary once your family is complete is a conversation, not an obligation, and it belongs to you rather than to a protocol.
Surveillance scans are not screening and they do not prevent a recurrence. They shorten the time between something appearing and someone removing it — which in borderline disease is usually enough, because recurrences are typically borderline again.
Bring the pathology report and the operation notes. In borderline disease those two documents settle almost everything, and the fertility question is usually answered by five lines in them rather than by an opinion. Women are often told the reassuring headline — it is not really cancer — and then left to work out on their own whether that means they can still have children.
Your first consultation at CION is free and runs to about 45 minutes. Cases that raise a question go to a tumour board with medical oncology, pathology and imaging in the room, which matters here because the commonest genuine dilemma — whether to go back for a staging operation after a cyst turned out to be borderline, and how much ovary that will cost — has no single right answer. It depends on the subtype, the growth pattern, your reserve and how much time you want to give yourself.
Be clear about who does what. Every operation in this pathway — cystectomy, ovary-sparing surgery, staging and any completion surgery later — is coordinated with specialist gynaecologic-oncology partner centres and may be billed there. Egg and embryo freezing and any treatment cycle happen at a reproductive medicine unit. What CION delivers in-house, across 35+ centres in Telangana and Andhra Pradesh, is the medical oncology side: genetic counselling and BRCA testing where the family history warrants it, chemotherapy in the uncommon situation where the disease proves invasive rather than borderline, nutrition support, and the long follow-up this diagnosis needs.
We will also say plainly when the honest answer is that nothing more needs doing. Not every borderline tumour needs a second operation, and no borderline tumour needs a decision made in the week you were told about it. If you want the plan reviewed before you commit to anything, book the free consultation and bring the paperwork.
Free, unhurried and with a specialist. Long enough to read the report properly and to talk about children without being rushed past it.
Cases that raise a question are reviewed by medical oncology, pathology and imaging together, rather than by one clinician deciding alone.
Surgery is coordinated with specialist gynaecologic-oncology partner centres and may be billed there. Fertility cycles are done at a reproductive medicine unit.
Borderline tumours need years of review. Follow-up can be delivered near where you live, across Telangana and Andhra Pradesh, rather than in one city hospital.
In most cases yes. Because borderline tumours do not invade, surgery does not have to remove both ovaries and the uterus to be adequate, and fertility-sparing surgery is a recognised option in international guidance. Most of these tumours are confined to one ovary when they are found, and many women conceive naturally afterwards. What affects your own chances is how much ovarian tissue is left, whether the other ovary is healthy, and your age and ovarian reserve rather than the diagnosis itself. Where natural conception does not happen, treatment cycles at a fertility unit are usually still possible. The conversation worth having early is not whether pregnancy is allowed, but how to reach it with the least ovarian tissue lost along the way.
It is a genuine trade rather than a right answer. Removing only the cyst preserves the most ovarian tissue, which matters if both ovaries are involved, if only one ovary remains, or if your reserve is already low. It also recurs more often. Removing the affected ovary and tube, while keeping the uterus and the healthy ovary, has the lower recurrence rate of the two fertility-sparing options but costs you half your ovarian tissue. Published series have not shown a survival difference between them, because recurrences after cyst-only surgery are usually borderline again and removable. Measure your ovarian reserve before deciding, and make the choice with the pathology report and your plans for children in the same conversation.
Pregnancy has not been shown to make borderline disease behave worse, and pregnancy after fertility-sparing surgery is common. Fertility treatment is more nuanced. The available evidence has not demonstrated that ovarian stimulation increases the risk of a borderline tumour progressing to invasive disease, but the studies are small and the follow-up is short, so no one should promise you certainty. In practice the decision is taken jointly by your gynaecologic oncologist and the fertility unit, usually after the pathology has been fully reviewed and the abdomen properly staged, and with surveillance of the preserved ovary built into the plan. Recurrence during or after either is generally borderline again and treated with further surgery.
There is no fixed waiting period written into guidelines for a borderline tumour, which surprises most women who have read about invasive ovarian cancer. Since chemotherapy has no established role here, there is no course of treatment to recover from before conceiving. The practical answer is that you wait for two things: healing from the operation, and clarity from the pathology. If the report raises a question about implants, microinvasion or missing staging, that gets settled first, because it may change what surgery you need. Once those are resolved and your surgeon is satisfied, waiting longer generally costs you ovarian reserve rather than buying safety. Ask for a specific answer for your case rather than a general one.
It is discussed, not mandated. Completion surgery removing the preserved ovary and sometimes the uterus is offered after childbearing in some situations, particularly where the disease was bilateral, where the pathology showed a micropapillary pattern or microinvasion, or where surveillance has been difficult. It is not automatic, and it is not urgent. Removing the remaining ovary before natural menopause brings its own consequences for bone, heart and quality of life, and those belong in the same conversation. The reasonable approach is to review the decision with your specialist once your family is complete, with the original pathology and your follow-up history in front of you, and to make it deliberately rather than by default.
The first consultation is free and runs to about 45 minutes. CION reviews the diagnosis, reads the pathology and operation notes with you, takes cases that raise a question to a tumour board, and manages the long follow-up this disease needs across more than 35 centres in Telangana and Andhra Pradesh. Delivered in-house: genetic counselling and BRCA testing where family history warrants it, chemotherapy in the uncommon situation where the disease proves invasive rather than borderline, nutrition support and survivorship care. Surgery of every kind here — cystectomy, ovary-sparing surgery, staging and any completion operation — is coordinated with specialist gynaecologic-oncology partner centres and may be billed there, and egg freezing or treatment cycles happen at a reproductive medicine unit. We say so upfront.